Dana Le, MHA’s Post

ŌURA, the maker of the innovative Oura Ring, has secured $75 million in #SeriesD funding from Dexcom, a leader in continuous glucose monitoring devices. This partnership positions both companies at the forefront of personalized health monitoring, combining Dexcom’s glucose biosensors with ŌURA’s sleep, activity, and recovery metrics. Key highlights: ✅ Integration of glucose data into Oura’s platform, empowering users to make informed lifestyle choices. ✅ Co-marketing and cross-selling opportunities between the two brands. ✅ First app integration expected by early 2025. ŌURA’s rapid growth continues, with 2.5 million rings sold and projected annual sales to double in 2024 to $500M, cementing its profitability and market leadership. This collaboration not only revolutionizes health insights but also highlights the growing demand for holistic, wearable health solutions. With Apple rumored to be developing noninvasive glucose monitoring technology, the space is heating up. https://lnkd.in/dSVEai-x

Dexcom and ŌURA have partnered to integrate glucose monitoring with Oura Rings, co-marketing their products. Dexcom’s $75M Series D investment raises Oura’s valuation to $5B. With 2.5M rings sold and 2024 sales projected at $500M, the partnership expands Dexcom’s consumer reach. Together, they’ll offer insights into glucose, sleep, and activity, with app integration set for 2025. This collaboration positions them as leaders in #health tracking, competing with Apple’s #noninvasive glucose technology efforts. Link: https://lnkd.in/emtMRCxz

Movano Health secures FDA clearance for EvieMED Ring - MobiHealthNews Exciting news in healthcare wearables! Movano Health has secured FDA 510(k) clearance for its EvieMED Ring, a smart device that monitors critical health metrics such as blood oxygen levels and heart rate. This milestone opens doors for clinical trials, remote patient monitoring, and partnerships with major payors and pharma companies. Movano aims to enhance compliance by integrating clinical-grade monitoring into everyday life. With ongoing trials at MIT for long COVID and chronic Lyme disease, the future looks promising for precision health solutions. #HealthTech #WearableTechnology #FDAApproval #RemotePatientMonitoring #DigitalHealth #ClinicalTrials #HealthcareInnovation ai.mediformatica.com #ring #health #clinical #clinicaltrial #monitoring #trial #movanohealth #wearable #clinicaltrials #heart #medical #payor #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3B5odAF)

𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐍𝐞𝐞𝐝𝐬 𝐏𝐫𝐨𝐩𝐞𝐥 𝐏𝐮𝐥𝐬𝐞 𝐎𝐱𝐢𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 $𝟑.𝟒𝟎 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏 ● 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/en5VQqYD Meticulous Research® forecasts that the pulse oximeter market will achieve a value of $3.40 billion by 2031, growing at a CAGR of 5.4% from 2024 to 2031. The market's growth is driven by rising hospitalization rates, increased application in newborn health, and a growing prevalence of chronic respiratory conditions like asthma and COPD. The accessibility of OTC pulse oximeters has further propelled adoption. However, challenges related to data accuracy and regulatory concerns around OTC devices limit broader market growth. Advancements in technology, including wearables and sensor improvements, are unlocking new growth opportunities. Still, mobile-based solutions for blood oxygen monitoring remain a competitive challenge. ● 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic, Philips, Masimo, Nonin Medical, Inc. Medical Solutions , Owlet Baby Care, ICU Medical, GE HealthCare. ● 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 : ⇨𝐄𝐮𝐫𝐨𝐩𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭:  https://lnkd.in/ges9CM5R ⇨𝐏𝐞𝐧 𝐍𝐞𝐞𝐝𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gnCxiJSY ⇨𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gvbfpz3U #PulseOximeter #OximeterMarket #HealthcareDevices #MedicalTechnology #HealthMonitoring #OxygenSaturation #RemotePatientMonitoring #MedicalEquipment #PulseOxInnovation #WearableHealthTech #HomeHealthcare #PulseOximetry #PatientCareSolutions #HealthcareTrends #DigitalHealth #VitalSignsMonitoring #OxygenMonitoring #HealthcareMarketGrowth #MedicalDeviceInnovation #PulseOximeterTrends

𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 (𝐂𝐆𝐌𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬, 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬 𝐒𝐞𝐜𝐮𝐫𝐞 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/gfNnDFUF The 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 (𝐂𝐆𝐌𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭 is making a significant impact on diabetes management, offering real-time insights that empower individuals to take control of their health. With advanced sensors and data analytics, CGMS has transformed how people monitor blood glucose, providing valuable data that leads to better decision-making and improved health outcomes. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡: Driven by the rising prevalence of diabetes and an increased focus on preventive healthcare, the CGMS market is set to experience robust growth. Innovations in sensor technology, coupled with the adoption of AI for data interpretation, are also accelerating demand. 𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: 1. Growing awareness of continuous monitoring benefits over traditional methods 2. Technological advancements in wearable devices 3. Increased focus on patient comfort and ease of use 𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤: As CGMS devices become more affordable and accessible, they are expected to reach broader segments of the global population. The focus on integration with digital health platforms will further enhance patient engagement, making CGMS a cornerstone in the future of diabetes care. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Abbott Dexcom Novo Nordisk Ypsomed AG GlySens Incorporated Insulet Corporation Senseonics, Incorporated Bayer 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gY7YAWDP #continuousglucosemonitoring #cgms #diabetescare #healthtech #markettrends #marketresearch #markettrends #businessinsights #globalindustry

𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 (𝐂𝐆𝐌𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐂𝐚𝐫𝐞 𝐒𝐞𝐜𝐮𝐫𝐞 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/gWGZ8fyY The 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐆𝐥𝐮𝐜𝐨𝐬𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 (𝐂𝐆𝐌𝐒) 𝐌𝐚𝐫𝐤𝐞𝐭 is making a significant impact on diabetes management, offering real-time insights that empower individuals to take control of their health. With advanced sensors and data analytics, CGMS has transformed how people monitor blood glucose, providing valuable data that leads to better decision-making and improved health outcomes. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡: Driven by the rising prevalence of diabetes and an increased focus on preventive healthcare, the CGMS market is set to experience robust growth. Innovations in sensor technology, coupled with the adoption of AI for data interpretation, are also accelerating demand. 𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: 1. Growing awareness of continuous monitoring benefits over traditional methods 2. Technological advancements in wearable devices 3. Increased focus on patient comfort and ease of use 𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤: As CGMS devices become more affordable and accessible, they are expected to reach broader segments of the global population. The focus on integration with digital health platforms will further enhance patient engagement, making CGMS a cornerstone in the future of diabetes care. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Abbott Dexcom Novo Nordisk Ypsomed AG GlySens Incorporated Insulet Corporation Senseonics, Incorporated Bayer 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gD8rGSfE #continuousglucosemonitoring #cgms #diabetescare #healthtech #markettrends #marketresearch #markettrends #businessinsights #globalindustry

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐮𝐥𝐬𝐞 𝐎𝐱𝐢𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐨 𝐇𝐢𝐭 $𝟑.𝟒𝟎 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏 𝐰𝐢𝐭𝐡 𝐑𝐨𝐛𝐮𝐬𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 ● 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/en5VQqYD As per a new report by Meticulous Research®, the pulse oximeter market is projected to grow to $3.40 billion by 2031, registering a CAGR of 5.4% from 2024 to 2031. The surge in hospitalizations, greater use of pulse oximeters for newborn screenings, and the rising prevalence of respiratory conditions such as COPD and asthma are major contributors to this growth. Additionally, the availability of OTC pulse oximeters is expanding consumer access. However, issues around device reliability and regulatory challenges for OTC products limit market potential. Key opportunities stem from innovations in wearable technology, advances in sensors, and new features in #pulse_oximeters. Nonetheless, emerging mobile-based alternatives for oxygen monitoring could challenge the market's growth trajectory. ● 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic, Philips, Masimo, Nonin Medical, Inc. Medical Solutions , Owlet Baby Care, ICU Medical, GE HealthCare. ● 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 : ⇨𝐄𝐮𝐫𝐨𝐩𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭:  https://lnkd.in/ges9CM5R ⇨𝐏𝐞𝐧 𝐍𝐞𝐞𝐝𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gnCxiJSY ⇨𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gvbfpz3U #PulseOximeter #OximeterMarket #HealthcareDevices #MedicalTechnology #HealthMonitoring #OxygenSaturation #RemotePatientMonitoring #MedicalEquipment #PulseOxInnovation #WearableHealthTech #HomeHealthcare #PulseOximetry #PatientCareSolutions #HealthcareTrends #DigitalHealth #VitalSignsMonitoring #OxygenMonitoring #HealthcareMarketGrowth #MedicalDeviceInnovation #PulseOximeterTrends

Pulse Oximeter Cleared: FDA Approves OxiWear's Ear-Worn Device for Continuous Health Monitoring OxiWear's ear-worn pulse oximeter, recently cleared by the FDA, represents a significant advancement in continuous health monitoring technology. Designed to provide real-time monitoring of blood oxygen saturation and pulse rate, the device aims to detect hypoxemia early, enhancing patient care both in clinical and home settings. The oximeter's advanced sensor and wireless capabilities ensure continuous data transmission, making it a valuable tool for healthcare providers. OxiWear, led by CEO Shavini Fernando, emphasizes the device's potential to save lives through early detection and timely intervention, marking a new milestone in wearable health technology. For more details please click the link! https://lnkd.in/dB3GZACN #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical 

𝐏𝐮𝐥𝐬𝐞 𝐎𝐱𝐢𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐒𝐮𝐫𝐠𝐞 𝐭𝐨 $𝟑.𝟒𝟎 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏: 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 ● 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/en5VQqYD Meticulous Research® forecasts that the pulse oximeter market will achieve a value of $3.40 billion by 2031, growing at a CAGR of 5.4% from 2024 to 2031. The market's growth is driven by rising hospitalization rates, increased application in newborn health, and a growing prevalence of chronic respiratory conditions like asthma and COPD. The accessibility of OTC pulse oximeters has further propelled adoption. However, challenges related to data accuracy and regulatory concerns around OTC devices limit broader market growth. Advancements in technology, including wearables and sensor improvements, are unlocking new growth opportunities. Still, mobile-based solutions for blood oxygen monitoring remain a competitive challenge. ● 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic, Philips, Masimo, Nonin Medical, Inc. Medical Solutions , Owlet Baby Care, ICU Medical, GE HealthCare. ● 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 : ⇨𝐄𝐮𝐫𝐨𝐩𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭:  https://lnkd.in/ges9CM5R ⇨𝐏𝐞𝐧 𝐍𝐞𝐞𝐝𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gnCxiJSY ⇨𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://lnkd.in/gvbfpz3U #PulseOximeter #OximeterMarket #HealthcareDevices #MedicalTechnology #HealthMonitoring #OxygenSaturation #RemotePatientMonitoring #MedicalEquipment #PulseOxInnovation #WearableHealthTech #HomeHealthcare #PulseOximetry #PatientCareSolutions #HealthcareTrends #DigitalHealth #VitalSignsMonitoring #OxygenMonitoring #HealthcareMarketGrowth #MedicalDeviceInnovation #PulseOximeterTrends

This could be big: "Oura valued at $5B following deal with medical device firm Dexcom." Wow. The convergence of two major trends - continuous glucose monitoring (CGM), which is gaining traction even beyond diabetic patients, and the rise of consumer-friendly wearables - is truly intriguing. This could be a game-changer - not just for managing chronic conditions but for overall health optimization; I could definitely see myself adopting this. What do you think? Are we on the brink of a new wave of wearable health tech that could finally make potentially clinical-grade insights mainstream? #DigitalHealth #WearableTech #Healthcare #Innovation #Oura #Dexcom https://lnkd.in/egiKx_wJ